Literature DB >> 2754745

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

M Haber1, C Reed, M Kavallaris, M D Norris, B W Stewart.   

Abstract

To study patterns of resistance at extreme but nevertheless clinically relevant drug concentrations, we developed a series of methotrexate-selected CCRF-CEM sublines, all of which were highly resistant to this antifolate (relative resistance, 10(2)- to greater than 10(5)-fold). The least methotrexate-resistant subline was completely sensitive to drugs associated with the multidrug resistance phenotype. However, more highly methotrexate-resistant sublines were significantly cross-resistant to vincristine, vinblastine, and dactinomycin (maximum relative resistance, 40-fold). These sublines were not cross-resistant to doxorubicin, daunorubicin, and teniposide. Regression analysis indicated that relative resistance to methotrexate was correlated with relative resistance to vincristine (r = 0.96) and vinblastine (r = 0.99). Such cross-resistance in highly methotrexate-resistant cells may have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754745     DOI: 10.1093/jnci/81.16.1250

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

Review 1.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

2.  Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

Authors:  M Haber; J Madafiglio; M D Norris
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 3.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells.

Authors:  A E Peaston; M Gardaneh; A V Franco; J E Hocker; K M Murphy; M L Farnsworth; D R Catchpoole; M Haber; M D Norris; R B Lock; G M Marshall
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.